1. Inoue M., Nobukuni Y, Ando Y., Hirota M., Hirata E., Morino Y.
Interorgan metabolism of glutathione as the defence mechanism against oxidative stress
In Nephrotoxicity of Antibiotics and Immunosuppressant
(eds., Tanabe T., Hook JB. & Endou H.), Elsevier Science Pub. Co, Amsterdam, p.51-60 (1986)

2. Inoue M., Ando Y., Hirota M., Ogino T., Ebashi I., Watanabe N., Araki S., Awai M., Morino Y.
Role of oxygen radicals in the pathogenesis of cellular injury caused by circulatory disturbance: Analysis by SOD derivatives that circulate bound to albumin and selectively accumulate in tissue whose local pH is decreased
In Microcirculation - an update 1,
(eds., Tsuchiya M., Asano T., Mishima Y. & Oda M.), Elsevier Science Pub. Co, Amsterdam, p.685-686(1987)

3. Ando Y., Inoue M., Hirota M., Morino. Y., Araki S.
Changes in glutathione metabolism during oxidative stress induced by paraquat and the effect of radical scavengers on the tissue injury
In Free Radicals in Digestive Disease,
(eds.,Tsuchiya M., Asano T., Mishima Y. & Oda M.), Elsevier Science Pub. Co, Tokyo, p.173-178(1988)

4. Ando Y., Ikegawa S., Miyazaki A., Inoue M., Morino Y., Araki S.
Studies of the fate of normal and variant prealbumin in the circulation
In Amyloid & Amyloidosis,
(eds., Araki S., Uchino F., Kito S. & Tsubura E.), Kluwer Academic Pub, Boston, p.335-341 (1989)

5. Araki S., Ikegawa S., Yi S., Ando Y., Miyazaki A.
Treatment of orthostatic hypotension in familial amyloidotic polyneuropathy with L-threo-3, 4-dihydroxy-phenylserine
In Amyloid & Amyloidosis,
(eds., Araki S., Uchino F., Kito S. & Tsubura E.), Kluwer Academic Pub, Boston p.839-844 (1989)

6. Ikegawa S., Tanase S., Morino Y., Yi S., Ando Y., Miyazaki A., Araki S.
Evaluation of serum variant prealbumin levels and its behavior after plasma exchange for familial amyloidotic polyneuropathy
In Amyloid & Amyloidosis,
(eds., Araki S., Uchino F., Kito S. & Tsubura E.), Kluwer Academic Pub, Boston, p.863-868 (1989)

7. Ando Y., Inoue M., Utsumi T., Morino Y., Araki S.
Synthesis of acylated SOD derivatives which bind to biomembrane surface
In Medical, Biochemical and Chemical Aspects of Free Radicals,
(eds., Hayaishi O., Niki E., Kondo M. & Yoshikawa T.), Elsevier Science Pub. Co, Amsterdam, p.619-622 (1989)

8. Inoue M., Ebashi I., Ando Y., Utsumi T., Waranabe N., Morino Y.
Control of in vivo behavior of human erythrocyte-type SOD by protein chemical engineering
In Medical, Biochemical and Chemical Aspects of Free Radicals,
(eds., Hayaishi O., Niki E., Kondo M. & Yoshikawa T.), Elsevier Science Pub. Co, Amsterdam, p.635-638 (1989)

9. Ando E., Ando Y., Kamata R., Inoue M., Morino Y.
Role of reactive oxygens in corneal inframmation: Analysis by acylated SOD derivatives with high affinity for plasma membrane surface
In Medical, Biochemical and Chemical Aspects of Free Radicals,
(eds., Hayaishi O, Niki E, Kondo M & Yoshikawa T.), Elsevier Science Pub. Co, Amsterdam, p.659-662 (1989)

10. Inoue M., Ando Y., Morino Y., Sakamoto K., Mori K., Akagi N.
Role of hepatic glutathione turnover in the pathogenesis of stress-induced gastric mucosal lesion
In Medical, Biochemical and Chemical Aspects of Free Radicals,
(eds., Hayaishi O., Niki E., Kondo M. & Yoshikawa T.), Elsevier Science Pub. Co, Amsterdam, p.1437-1440 (1989)

11. Inoue M., Ando Y.
Photooxidative inactivation of membrane-bound enzymes: Pathological significance of heme-related metabolites
In Vitamin E: Biochemistry and Health Implications (Annals of the New York Academy of Sciences, Vol 570),
(eds., Anthony TD., MacHlin LJ., Packer L. & Pryor WA.), New York Academy of Science, New York, p.458-460 (1989)

12. Araki S., Mita S., Ide M., Ikegawa S., Yi S., Ando Y., Murakami T., Miyazaki A., Maeda S., Shimada K.
Molecular genetics of familial amyloidotic polyneuropathy type I
In Charcot-Marie-Tooth Disorder (Neurology & Neurobiology S.),
(eds., Lovelace RE. & Shapiro HK.), John Wiley & Sons Inc, Hoboken, p.263-268 (1990)

13. Ando Y., Araki S., Shimoda O., Ikegawa S., Kano T.
Detection of autonomic dysfunction in patients with familial amyloidotic polyneuropathy (FAP) by laser Doppler method
In Amyloid & Amyloidosis,
(eds., Natovig JB, Forre O, Husby G, Husebekk A, Skogen B, Sletten K & Westermark P.), Kluwer Academic Publishers, Boston, p.778-780 (1991)

14. Ikegawa S., Yi S., Araki S., Ando Y., Miyazaki A.
Re-evaluation of 134 patients with familial amyloidotic polyneuropathy in Japan, Kumamoto focus
In Amyloid & Amyloidosis 1990,
(eds., Natovig JB., Forre O., Husby G., Husebekk A., Skogen B., Sletten K. & Westermark P. ), Kluwer Academic Publishers, Boston, p.675-678 (1991)

15. Ando E., Ando Y., Maruoka S., Ksakai Y., Watanabe S., Yamashita R., Okamura R., Araki S.
Ocular miroangiopathy in familial amyloidotic polyneuropathy
In Amyloid & Amyloidosis 1990,
(eds., Natovig JB., Forre O., Husby G., Husebekk A., Skogen B., Sletten K. & Westermark P.), Kluwer Academic Publishers, Boston, p.835-838 (1991)

16. Kawaguchi Y., Ando Y., Ikegawa S., Araki S.
Gastrointestinal malabsorption in familial amyloidotic polyneuropathy (FAP): Ursodeoxychoric acid absorption test with FAP
In Amyloid & Amyloidosis 1990,
(eds., Natovig JB., Forre O., Husby G., Husebekk A., Skogen B., Sletten K. & Westermark P.), Kluwer Academic Publishers, Boston, p.966-969 (1991)

17. Araki S., Ikegawa S., Murakami T., Nishiguchi S., Yi S., Ando Y., Miyazaki A.
Atypical cases of familial amyloidotic polyneuropathy (FAP) type I in Japan
In Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders, (eds., Costa P., Costa A., Freitas F. & Saraiva M J M.), Arquivos de Medica, Porto p.267-270, (1991)

18. Ikegawa S., Tanaka Y., Yi S., Fukushima T., Ando Y., Miyazaki A., Araki.
Therapeutic effect of periodic plasma exchange for familial amyloidotic polyneuropathy (type I)
In Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders, (eds., Costa P., Costa A., Freitas .F & Saraiva M J M.), Arquivos de Medica, Porto p.276-279, (1991)

19. Ando Y., Okamura R., Ando E., Maruoka S., Yamashita R., Inada K., Murakami T., Yi S., Miyazaki A., Ikegawa S., Araki S.
Changes of the retina in gene carriers and patients with familial amyloidotic polyneuropathy
In Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders, (eds., Costa P., Costa A., Freitas F. & Saraiva M J M.), Arquivos de Medica, Porto p313-316, (1991)

20. Ando Y., Yi S., Inoue M., Uekawa K., Ikegawa S., Nakagawa T., Miyazaki A., Araki S.
Disturbed metabolism of glucose related hormones in familial amyloidotic polyneuropathy
In Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders, (eds., Costa P., Costa A., Freitas F. & Saraiva MJM.), Arquivos de Medica, Porto p.345-350 (1991)

21. Araki S., Ikegawa S., Ando Y., Yi S., Miyazaki A.
Experiences of L-threo-3, 4-dihydroxyphenylserine (L-DOPS) treatment for orthostatic hypotension and gatrointestinal disturbances in familial amyloidotic polyneuropathy
In Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders, (eds., Costa P., Costa A., Freitas F. & Saraiva M J M.), Arquivos de Medica, Porto p.387-390 (1991)

22. Ando Y., Araki S., Ikegawa S., Shimoda S., Kano T.
Analysis of autonomic dysfunction by laser Doppler flowmetry in patients with familial amyloidotic polyneuropathy
In New Trends in Autonomic Nervous System Research,
(eds.,Yoshikawa M., Uono M., Tanabe H. & Ishikawa S.), Elsevier Science Ltd., Amsterdam p.217 (1991)

23. Ando Y., Tanaka Y., Araki S., Ando M.
Evaluation of autonomic disorders in familial amyloidotic polyneuropathy.
Proceedings of European Neurophysiologiy Congress,
(ed., Louis S.), Ciba Publishing Co., Barsell, p.37-42 (1992)

24. Maruoka S., Ando E., Inada K., Okamura R., Yamashita R., Ando Y., Araki S.
Histopathological changes in the lacrimal gland in familial amyloidotic polyneuropathy: Pathogenesis of lacrimal deficiency
In Current Aspect in Ophthalmology,
(ed., Shimizu K.), Elsevier Science Ltd., Amsterdom, p.203-206 (1992)

25. Tanaka Y., Ando Y., Yamashita T., Kumamoto T., Uchino M., Ando M.
Binding of mutant transthyretin (Val30-Met) with low density lipoprotein (LDL): A novel function of lipoproteins
In Amyloid & Amyloidosis 1993,
(eds., Kisilevsky R., Gauldie J., Benson MD., Muckle TJ., Frangione B. & Young ID.), Palthenon Publishing, London, p.441-443 (1994)

26. Yamashita T., Ando Y., Tanaka Y., Yonehara T., Tashima K., Sakashita N., Uchino M., Ando M.
Decreased NO radical synthesis in the peripheral vessels of patients with familial amyloidotic polyneuropathy (FAP)
In Amyloid & Amyloidosis 1993,
(eds., Kisilevsky R, Gauldie J, Benson MD, Muckle TJ, Frangione B & Young ID), Palthenon Publishing, London, p.670-672 (1994)

27. Ando Y., Ando E., Tanaka Y., Tashima K., Uchino M., Okamura R., Ando M.
Evaluation of autonomic disorders in familial amyloidotic polyneuropathy (FAP): Analysis of each clinical stage of FAP
In Amyloid & Amyloidosis 1993,
(eds., Kisilevsky R., Gauldie J., Benson MD., Muckle TJ., Frangione B. & Young ID.), Palthenon Publishing, London, p.673-675 (1994)

28. Ando Y., Tanaka Y., Yamashita T., Kumamoto T., Uchino M., Ando M.
Changed affinity of apolipoprotein AII to high density lipoprotein (HDL) in patients with familial amyloidotic polyneuropathy
In Amyloid and Amyloidosis 1993,
(eds. Kisilevsky R., Gauldie J., Benson MD., Muckle TJ., Frangione B. & Young ID.), Palthenon Publishing, London, p.438-440 (1994)

29. Ando Y., Yamashita T., Tanaka Y., Tashima K., Yonehara T., Sakashita N., Uchino M., Ando M.
Role of NO radical in the peripheral vessels in patients with familial amyloidotic polyneuropathy
In Frontiers of Reactive Oxygen Species in Biology and Medicine,
(eds., Asada K & Yoshikawa), Elsevier Science Pub Co., Tokyo, p. 237-238 (1994)

30. Yamashita T., Ando Y., Nakamura M., Hashimoto M., Uemura Y., Obayashi K., Terazaki H, Suga M, Uchino M., Ando M
Down regulation of transthyretin (TTR) (Met30) by replacement of normal protein
In Amyloid and Amyloidosis 1998,
(eds., Kyle RA & Gartz MA.), CRC Press-Parthenon Publishers, New York p.264-266, (1999)

31. Nakamura M., Yamashita T., Ando Y., Hamidi Asl K., Tashima K., Ohlsson PI,. Wang L., Benson MD.
A new transthyretin variant (Ile49) associated with familial amyloidotic polyneuropathy
In Amyloid and Amyloidosis 1999,
(eds., Kyle RA. & Gartz MA.), CRC Press-Parthenon Publishers, New York, p.309-311 (1999)

32. Ando Y., Gustavsson A., Suhr O., Ohlsson PI., Terazaki H., Obayashi K., Yamashita T., Ando E., Negi A., Ando M., Westermark P.
Impact of cystein (Cys) -conjugation and pH on amyloid formation of wild type and Met30 transthyretin (TTR)
In Amyloid and Amyloidosis 1998,
(Kyle RA. & Gartz MA.), CRC Press-Parthenon Publishers, New York, p.44-47 (1999)

33. Gustavsson A., Ando Y., Sandgren O., Ando E., Westermark P.
Immunoelectron microscopy reveal differences between amyloid fibrils from the vitreous of FAP patients with the TTR Met30 and TTR Cys114 mutations
In Amyloid and Amyloidosis 1998,
(eds., Kyle RA. & Gartz MA.), CRC Press-Parthenon Publishers, p.241-243, New York (1999)

34. Terazaki H., Ando Y., Yoshimatsu S., Sakashita N., Tada S., Yamashita T., Suga M., Uchino M., Ando M.
Macroscopic and microscopic manifestation of the gastrointestinal tract in familial amyloidotic polyneuropathy (FAP Met30)
In Amyloid and Amyloidosis 1998,
(eds., Kyle RA. & Gartz MA.), CRC Press-Parthenon Publishers, New York p.249-251 (1999)

35. Ohlsson PI., Ando Y., Suhr OB.
Heterogeneity of amyloid in transthyretin related amyloidosis
In Amyloid and Amyloidosis 1998,
(eds., Kyle RA. & Gartz MA.), CRC Press-Parthenon Publishers, New York, p. 252-254 (1999)

36. Nakamura M., Ando Y., Kluve-Beckerman B., Hamidi Asl K., Liepnieks J J., Benson MD.
Dual expression of normal TTR and Met30 TTR using baculovirus system
In Amyloid and Amyloidosis 1998,
(eds., Kyle RA & Gartz MA.), CRC Press-Parthenon Publishers, New York, p258-260 (1999)

37. Olofsson A., Thylen C., Ando Y., Lundgren E.
Transthyretin tyr114cys provides a connection between dissociation of the tetramer and exposure of the C+loop D strand
In Amyloid and Amyloidosis 1999,
(eds., Kyle RA. & Gartz MA.), CRC Press-Parthenon Publishers, New York, p.267-269 (1999)

38. Ando Y., Almeida MR., Ando E., Negi A., Suhr O., Terazaki H., Obayashi K., Tashima K., Saraiva MJM.
Biochemical characterization of transthyretin Cys114 associated with familial amyloidotic polyneuropathy
In Amyloid and Amyloidosis 1998,
(eds., Kyle RA. & Gartz MA.), CRC Press-Parthenon Publishers, New York, p.288-290, (1999)

39. Shimamura M., Sugiuchi H., Suzaki E., Haruta S., Eto H., Hayashi S., Chikaura Y., Kitagawa J., Uji Y., Ando Y., Okabe H.
Standardization of reference intervals for clinical chemistry data in Kumamoto prefecture
In Proceedings of the 9th International Symposium on Quality Control and Management,
(eds., Kanno H, Okabe H, Tatsumi N, Mori M & Ichiyama S.), Eibun Press, Osaka, p.112-115 (2001)

40. Haruta S., Sugiuchi H., Suzaki S., Harada S., Hayashi S., Chikaura Y., Shimamura M., Eto H., Uji Y., Ando Y., Okabe H.
Standardization for enzyme tests in Kumamoto prefecture
In Proceedings of the 9th International Symposium on Quality Control and Management,
(eds., Kanno H., Okabe H., Tatsumi N., Mori M. & Ichiyama S.), Eibun Press, Osaka, p.116-118 (2001)

41. Manabe M., Sugiuchi H., Ueno T., Yamashita S., Yonemura A., Nagata S., Uji Y., Ando Y., Okabe H.
Standardization of laboratory data by using an animal derived caribrator
In Proceedings of the 9th International Symposium on Quality Control and Management, Kanno H, Okabe H, Tatsumi N, Mori M and Ichiyama S (Ed.), Eibun Press, Osaka, p.119-121 (2001)

42. Obayashi K., Ando Y., Nakamura M., Terazaki H., Yamashita T., Uchino M.
Evaluation of gastric function by electrogastrogram in patients with familial amyloidotic polyneuropathy (FAP)
In Amyloid and Amyloidosis,
(ed. Bély M.), Merck & Co., Budapest, p.360-361 (2002)

43. Terazaki H., Ando Y., Tajiri T., Haraoka K., Nakamura M., Obayashi K., Misumi S., Shoji S., Hata K., Nakagawa K., Ishizaki T., Uemoto S., Inomata Y., Tanaka K., Okabe H.
Presence of autoantibody against ATTR Val30Met after sequential liver transplantation
In Amyloid and Amyloidosis 2001,
(ed., Bély M.), Merck & Co., Budapest, p.343-345 (2002)

44. Ando Y., Ando E., Haraoka K., Fukushima M., Obayashi K., Nakamura M., Terazaki H., Uchino M., Okabe H.
Vitreous amyloid is formed by transthyretin (TTR) from the retina in familial amyloidotic polyneuropathy (FAP)
In Amyloid and Amyloidosis 2001,
(ed., Bély M.), Merck & Co., Budapest, p.346-347 (2002)

45. Hata K., Ando Y., Haraoka K., Tajiri T., Nakamura M., Obayashi K., Yamashita T., Nakagawa K., Ishizaki T.
Change in amyloid formation process of transthyretin (TTR) in oxidative stress induced rats
In Amyloid and Amyloidosis 2001,
(ed., Bély M.), Merck & Co., Budapest, p.352-353 (2002)

46. Nakamura M., Ando Y., Haraoka K., Terazaki H., Yamashita T., Obayashi K., Hirano T., Uchino M.
Oculo-leptomeningeal amyloidosis before and after liver transplantation in patients with familial amyloidotic polyneuropathy (FAP) ATTR Y114C
In Amyloid and Amyloidosis 2001,
(ed., Bély M.), Merck & Co., Budapest, p.358-359 (2002)

47. Tajiri T., Ando Y., Hata K., Kamide K., Hashimoto M., Nakamura M., Terazaki H., Kai H., Haraoka K., Imasato A., Takechi K., Nakagawa K., Okabe H., Ishizaki T.
Amyloid formation in rat transthyretin (TTR)
In Amyloid and Amyloidosis 2001,
(ed. Bély M.), Merck & Co., Budapest, p.362-363(2002)

48. Tanoue Y., Haraoka K., Ando Y., Hata K., Son K., Nakamura M., Tajiri T., Nakagawa K., Ishizaki T.
Presence of variant transthyretin (TTR) in aqueous humor of patients with familial amyloidotic polyneuropathy (FAP ATTR Val30Met) after liver transplantation
In Amyloid and Amyloidosis 2001,
(ed., Bély M.), Merck & Co., Budapest, p.367-368 (2002)

49. Haraoka K., Ando Y., Nakamura M., Kai H., Terazaki H., Yamashita T., Ando M.
Lactoferrin amyloidosis in the Cornea
In Amyloid and Amyloidosis 2001,
(ed., Bély M.), Merck & Co., Budapest, p.399-400 (2002)

50. Araki S., Ando Y.
Familial amyloidotic polyneuropathy -Progress in Kumamoto, Japan, 1967-2002
(ed., Ando Y. ), Kumamoto Copy Co, Kumamoto (2002)

51. Ando Y.
Aging and amyloidosis
In Proceeding of the 22nd World Congress of Pathology & Laboratory Medicine, (ed., Park AE.), Monduzzi Editore, Bologna, p.99-103 (2003)

52. Obayashi K., Ando Y., Miida T., Nakamura M., Yamashita T., Ueda M., Haraoka K., Terazaki H., Okada M.
Macroscopic assessment of skin venules in fingers using near-infrared spectrophotoscopy -As a useful marker of autonomic dysfunction
In Amyloid and Amyloidosis 2004,
(eds., Grateau G., Kyle RA. & Skinner M.), CRC Press, New York, p.334-336 (2005)

53. Nakamura M., Ando Y., Ueda M., Kawaji T., Yamashita T., Kim J M., Haraoka K., Terazaki H., Nagahara S., Sano A., Saitoh S., Uchino M.
Targeted conversion of the transthyretin gene in vitro and in vivo
In Amyloid and Amyloidosis 2004,
(Eds., Grateau G., Kyle RA. & Skinner M.), CRC Press, New York, p.503-504 (2005)

54. Ueda M., Ando Y., Haraoka K., Matsui T., Takamune M., Saito S., Nakamura M., Terazaki H., Yamashita T., Xuguo S., Kim J., Tateishi T., Shoji S., Hoshi Y., Ishihara T., Otagiri M., Uchino M.
Analyses of the amyloid fibrils in bovine amyloidosis in Hokaido district, Japan
In Amyloid and Amyloidosis 2004, (eds., Grateau G., Kyle RA. & Skinner M.), CRC Press, New York, p.200-202 (2005)

55. Yamashita T., Ando Y., Nakamura M., Haraoka K., Xuguo S., Terazaki H., Ueda M., Ikeda T., Saito S., Kawaji T., Hirai T., Washimi Y., Uchino M.
Hereditary cerebral amyloid angiopathy associated with ATTR Tyr114Cys
In Amyloid and Amyloidosis 2004,
(eds., Grateau G., Kyle RA. & Skinner M.), CRC Press, New York, p.391-393 (2005)

56. Terazaki H., Okuda A., Katase K., Nakamura M., Ueda M., Kim JM., Haraoka K., Ando Y., Sasaki Y.
A heterozygotic Japanese patient with familial Mediterranean fever (FMF) Pyrin M694I
In Amyloid and Amyloidosis 2004,
(Grateau G, Kyle RA and Skinner M (Eds.), CRC Press, New York, p.278-280 (2005)

57. Kawaji T., Ando Y., Nakamura M., Yamamoto K., Ando E., Fukushima M., Hirata A., Tanihara H.
Pigmentd cilliary ephelium cells synthesized tranthyretin in the rabbit eye
In Amyloid and Amyloidosis 2004,
(eds., Grateau G., Kyle RA. & Skinner M.), CRC Press, New York, p317-319 (2005)

58. Ando Y.
Genotype-phenotype correlations and management in transthyretin (TTR) related amyloidosis
In Amyloid and Amyloidosis 2004,
(eds., Grateau G., Kyle RA. & Skinner M.), CRC Press, New York, p.300-302 (2005)

59. Motomiya Y., Haraoka K., Xuguo S., Morita H.& Ando Y.
Studies on unfolded β2-microglobilin C-terminal 92 to 99 in dialysis related amyloidosis
In Amyloid and Amyloidosis 2004,
(eds., Grateau G., Kyle RA. & Skinner M.), CRC Press, New York, p.426-428 (2005)

60. Berk JL., Bisbee AB., Kelly JW., Dyck PJ., Falk RH., Ando Y., Coelho T., Ikeda S., Merlini G., Suhr OB. Skinner M., the Diflunisal Investigators Consortium.
Clinical trial for TTR Amyloidosis using deflunisal in “XIth International Symposium on Amyloidosis”,
(eds., Skinner M., Berk J., Connors L. & Seldin D.), CRC Press, New York, p.387-389 (2007)

61. Himeno S., Ueda M., Nakamura M., Yamashita T., Obayashi K., Sun X., Misumi Y., Shinriki S., Ueda A., Uji Y., Saito S., Kim J., Meng W., Ando Y.
Urinary transthyretin: A possible biochemical marker in the earry stage of renal dysfunction
In “XIth International Symposium on Amyloidosis”,
(eds., Skinner M., Berk J., Connors L. & Seldin D.), CRC Press, New York, p.146-148 (2007)

62. Kakizoe N., Ando Y., Kawaji T., Ando E., Sandgren O., Suhr OB., Tanihara H.
Uunique Phenotype of Vitreous Amyloidosis in different endemic AREAS
In “XIth International Symposium on Amyloidosis”,
(eds., Skinner M., Berk J., Connors L. & Seldin D.), CRC Press, New York, p.149-151, (2007)

63. Kim J., Motomiya Y., Nakamura M., Ueda M., Saito S., Misumi Y., Himeno S., Obayashi K., Shinriki S., Meng W., Semba U., Kai H., Ando Y.
Role of the C-terminal amino acids in β2-microglobulin amyloid formation
In “XIth International Symposium on Amyloidosis”,
(eds., Skinner M., Berk J., Connors L. & Seldin D.), CRC Press, New York, p.16-18 (2007)

64. Misumi Y., Ando Y., Nakamura M., Yamashita T., Himeno S., Ueda M., Obayashi K., Sun X., Saito S., Kim J., Shinriki S., Meng W., Ueda A., Uchino M.
An autopsy case of familial amyloidotic polyneuropathy ATTR val30met 10 years after liver transplantation: changes in the Amount of amyloid deposits in the pancreas
In “XIth International Symposium on Amyloidosis”,
(eds., Skinner M., Berk J., Connors L. & Seldin D.), CRC Press, New York, p.169-171 (2007)

65. Obayashi K., Yamashita T., Ueda M., Nakamura M., Asonuma K., Inomata Y., Uchino M., Tanaka K., Ando Y.
Amyloid neuropathy in a Japanese domino liver-transplanted recipient
In “XIth International Symposium on Amyloidosis”,
(eds., Skinner M., Berk J., Connors L. & Seldin D.), CRC Press, New York, p172-174 (2007)

66. Okamoto S., Yamashita T., Ando Y., Nakamura M., Ueda M., Uchino M.
Cardiomyopathy in FAP val30met patients with and without liver transplantation
In “XIth International Symposium on Amyloidosis”,
(Skinner M., Berk J., Connors L. & Seldin D.), CRC Press, New York, p180-181 (2007)

67. Saito S., Ando Y., Ueda M., Kim J., Nakamura M., Yamashita T., Obayashi K., Misumi Y., Shinriki S., Himeno S., Meng W., Ishima Y., Akaike T., Otagiri M.
Effect of nitric oxide in transthyretin-reloated amyloidosis
In “XIth International Symposium on Amyloidosis”,
(eds., Skinner M., Berk J., Connors L. & Seldin D.), CRC Press, New York, p.185-187, (2007)

68. Sato T., Susuki S., Miyata M., Ando Y., Shuto T., Suico MA., Kai H.
Inhibition of intracellular tetramerization induces the proteasomal degradation of amyloidogenic transthyretin variants
In “XIth International Symposium on Amyloidosis”,
(eds., Skinner M., Berk J., Connors L., & Seldin D.), CRC Press, New York, p.188-190 (2007)

69. Shinriki S., Ueda M., Yamashita T., Obayashi K., Sun X., Himeno S., Ueda A., Misumi Y., Saito S., Kim J., Meng W., Shinohara M., Ando Y.
Amyloid deposition in the tongue of patients with familial amyloidotic polineuropathy
In “XIth International Symposium on Amyloidosis”,
(eds., Skinner M., Berk J., Connors L. & Seldin D.), CRC Press, New York, p.196-198 (2007)

70. Ueda A., Ueda M., Yamashita T., Hirano T., Nakamura M., Misumi Y., Meng W., Ito T., Uchino M., Ando Y.
proliferation of smooth muscle cells in the tunica intima of cerebral vessels in familial amyloidtic polyneuropathy ATTR Y114C
In “XIth International Symposium on Amyloidosis”,
(eds., Skinner M., Berk J., Connors L. & Seldin D.), CRC Press, New York, p202-204 (2007)

71. Ueda M., Ando Y., Nakamura M., Yamashita T., Obayashi K., Misumi Y., Shinriki S., Ueda A., Zeledon R ME., Himeno S., Saito S., Kim J., Meng W., Uchino M.
FK506 inhibits murine AA amyloidosis without modupationg serum SAA levels
In “XIth International Symposium on Amyloidosis”,
(eds., Skinner M., Berk J., Connors L. & Seldin D.), CRC Press, New York, p99-101 (2007)

72. Yamashita T., Ando Y., Ueda M., Nakamura M., Okamoto S., Hirahara T., Ueda A., Misumi Y., Obayashi K., Uchino M.
Effects of liver transplantation on hereditary cerebral amyloido angiopathy associated with ATTR Y114C
In “XIth International Symposium on Amyloidosis”,
(eds., Skinner M., Berk J., Connors L. & Seldin D.), CRC Press, New York, p. 211-213 (2007)

73. Ando Y.
Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP)
In Proceedings of XXIV World Congress of Pathology and Laboratory Medicine,
(ed., Meng LL.) ISI, Philadelphia, USA, p.249-254 (2007)

74. Ando Y.
Combined genomic and proteomic-based screening for hereditary amyloidosis mutations
Pathology update 2009 in conjunction with was PaLM XXV World Congress Abstract Publication
Pathology, 41 (supplement), Royal College of Pathologists of Australasia, Sydney, p.28 (2009)

75. Ando Y., Nakamura M., Ueda M. & Jono H.
New therapeutic approaches for familial amyloidotic polyneuropathy (FAP)
Recent Advances in Transthyretin Evolution, Structure, and Biological Functions, (eds. Richardoson SJ. & Cody V.), Springer-Verlag Berlin Heidelberg, p.215-238 (2009)

76. Nakamura S, Ueda M, Ageyama N, Ando Y., Torii R.
Transthyretin amyloidosis in aged vervet monkeys, as a candidate for the spontaneous animal model of senile systemic amyloidosis
In “Amyloidosis”, Sarantseva S (Ed.), InTech - Open Access Publisher, p. 181-190 (2011)

77. Jono H, Ando Y.
Potential impact of albumin on amyloidosis
In “Human Serum Albumin”, Otagiri M (ed), p385-400 (2013)

78. Ando Y., Ueda M.
Antibody therapy for transthyretin-related hereditary amyloid polyneuropathy: another therapeutic option.
Amyloid, 24, 113-114 （2017）